Page 6 - Daniel Claassen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting

Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoDaniel claassenDavid stamlerVanderbilt university medical centerNational institute of healthMeeting of the american neurological associationEuropean commissionAlterity therapeuticsMultiple system atrophyAnnual meetingAmerican neurological associationDeep learning segmentation improves precisionVolume assessmentSubcortical structuresChief executive officer

Families fighting Huntington s disease find strongest support at Vanderbilt facility

To many people, Eva Angelina Romero s mom appeared to be fine.

United statesVanderbilt universityDaniel claassenKatherine mcdonnellAmy brownMarle kathanElisa haleEva angelina romeroDanielle buchananCenters of excellenceVanderbilt university medical centerHuntington disease society of americaDisease societyHermitage golfZoom happy hourBobb marle

Alterity Therapeutics announces poster presentation from major study

Alterity Therapeutics announces poster presentation from major study
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Daniel claassenDavid stamlerMovement disordersInternational congressAlterity therapeuticsMultiple system atrophyWearable sensorsQuantitative motor assessmentsAssociate professorVanderbilt university medical centerPrincipal investigator

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson s Disease and Movement Disorders

/PRNewswire/ Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying.

United statesSan franciscoDaniel claassenDavid stamlerMovement disordersVanderbilt university medical centerNational institute of healthEuropean commissionInternational congressAlterity therapeuticsValidates useWearable sensorsOngoing phaseMultiple system atrophyQuantitative motor assessmentsAssociate professor

Alterity Therapeutics Announces Presentation of Wearable Sensor Data from the bioMUSE Natural History Study at the International Congress of Parkinson s Disease and Movement Disorders - Alterity Therapeutics (NASDAQ:ATHE) - Press Release

- Wearable sensors strongly correlated with clinical scales on motor impairment - - bioMUSE Study Validates Use of Wearable Sensors for Alterity's Ong

United statesSan franciscoDaniel claassenDavid stamlerMovement disordersInternational congressVanderbilt university medical centerEuropean commissionAlterity therapeuticsValidates useWearable sensorsOngoing phaseMultiple system atrophyQuantitative motor assessmentsAssociate professorPrincipal investigator